Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts ...

Morgan Stanley (NYSE:MS) has begun coverage of Genmab (CSE:GMAB) (NASDAQ:GMAB) with an Equal-Weight rating and a price objective of $24, reduced slightly from the previous $25 target.

Investing.com -- Morgan Stanley (NYSE: MS) has named KKR & Co. Inc. (NYSE: KKR) its new top pick in the brokers, asset ...

Morgan Stanley (NYSE:MS – Get Free Report) announced that its Board of Directors has authorized a share buyback program on Tuesday, July 1st, RTT News reports. The company plans to buyback $20.00 ...

Morgan Stanley stock hit a new 52-week high, climbing to $142.63 on strong trading volume. The financial powerhouse reported ...

In the latest trading session, Morgan Stanley (MS) closed at $142.86, marking a +1.27% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.48%. At the ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...

Morgan Stanley (MS) is currently at $142.31, up $1.24 or 0.88% --Would be new all-time closing high (Based on available data back to Feb. 23, 1993) --Would be the first record close since Feb. 6, 2025 ...

View the latest Morgan Stanley (MS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Buying $1000 In MS: If an investor had bought $1000 of MS stock 5 years ago, it would be worth $2,906.60 today based on a price of $141.90 for MS at the time of writing.

I’m 67 and my wife is 66, and we would like to retire at age 70.

Morgan Stanley’s board has greenlit a $20 billion stock buyback, representing up to 8.9% of its outstanding shares. This move ...